In GBM, particularly in recurrent glioblastoma (rGBM), EPHA2 and EPHA3 show conspicuous co-expression, constituting a signaling axis that fuels tumor evolution and therapeutic escape 94. The gene discussed is EPHA3; the disease is glioblastoma.